The largest database of trusted experimental protocols

Hitrap capto s column

Manufactured by GE Healthcare
Sourced in United Kingdom

The HiTrap Capto S column is a pre-packed cation exchange chromatography column designed for fast and efficient purification of proteins and biomolecules. It features a high-capacity, cross-linked agarose-based resin with sulfonate functional groups that enable strong cation exchange interactions. This column is suitable for use in small-scale research applications and process development workflows.

Automatically generated - may contain errors

3 protocols using hitrap capto s column

1

Overexpression and Purification of TEM-1 β-Lactamase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Overexpression
plasmids were constructed by subcloning TEM-1 into a pET24 vector
(Life Technologies) with its native export signal sequence replaced
by the OmpA signal sequence to maximize export efficiency.21 (link) Variants were constructed via site-directed
mutagenesis and verified by DNA sequencing. Plasmids were transformed
into BL21(DE3) cells (Life Technologies) for expression under a T7
promoter control. Cells were induced with 1 mM IPTG at OD = 0.6 and
grown at 18 °C for 15 h before harvesting.
TEM β-lactamases
were isolated from the periplasmic fraction using osmotic shock lysis:
Cells were resuspended in 30 mM Tris-Cl, pH 8, and 20% sucrose and
stirred for 10 min at room temperature. After centrifugation, the
pellet was resuspended in ice-cold 5 mM MgSO4 and stirred
for 10 min at 4 °C. After centrifugation, the supernatant was
dialyzed against 20 mM sodium acetate, pH 5.5, and purified using
cation exchange chromatography (HiTrap Capto S column, GE Healthcare).
All variants eluted between 10 and 20% NaCl. Proteins were concentrated,
dialyzed in storage buffer (20 mM Tris, pH 8.0), and final concentrations
were measured in Edelhoch buffer using calculated extinction coefficients
based on the number of tryptophans, tyrosines, and disulfide bonds.22 (link)
+ Open protocol
+ Expand
2

Recombinant Tau Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
2N4R tau lacking the
endogenous cysteine residues (C291S and C322S) and the relevant cysteine
mutants (S262C and K311C), created by standard site-directed mutagenesis,
were expressed from a pet29b vector in BL21 Gold (DE3) cells (Agilent
Technologies). Cultures were grown to an OD600 of 0.6 and then induced
with 0.4 mM IPTG and left to express at 18 °C overnight. Cells
were harvested by centrifugation, resuspended in 50 mM MES (pH 6.5),
5 mM DTT, 0.1 mM PMSF, and lysed via sonication (1 min 30 s; 5 s on,
10 s off; 40% amplitude) on ice. The lysed mixture was centrifuged,
and tau was isolated via cation exchange using a Hitrap CaptoS column
(GE Healthcare LifeSciences, Little Chalfont, U.K). Fractions containing
tau as determined by gel electrophoresis were pooled and precipitated
by the addition of 20% (w/v) ammonium sulfate on ice overnight. The
precipitated protein was pelleted by centrifugation and then resuspended
in SSPE buffer containing 5 mM DTT. Pure tau was finally isolated
via size exclusion chromatography using a Superdex 200 Increase 10/300
GL column (GE Healthcare LifeSciences, Little Chalfont, U.K.) equilibrated
with the aforementioned SSPE buffer; only the purest fractions as
assessed by gel were kept for experiments.
+ Open protocol
+ Expand
3

Purification and Analysis of Humanized di-scFv Antibody Fragments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine (yeast) di-scFv prototype was expressed in P. pastoris and purified using approaches described elsewhere [9] . For novel di-scFv prototype expression, cDNAs encoding the murine di-scFv sequence or each of the 16 humanized variants were synthesized and subcloned into a proprietary CHO expression vector. Stable CHO cell pools expressing the antibody fragments were generated in CD-CHO media (Invitrogen) and a base feed utilized for the expression culture (bolus feed was added on day four, and the cultures harvested at day eight).
The medium was subsequently centrifuged to remove cellular matter, and filtered using a 0.22 µm pore-sized filter. Purification of di-scFv variants was achieved using a two-step process including ion exchange chromatography and NaCl gradient elution (over 20 column volumes) on an Äkta system equipped with a HiTrap Capto S column at a (5 mL/min flow rate) (GE Healthcare). Following purification, samples were concentrated using Amicon Ultra-15 filters (Millipore) and subjected to analysis of monomeric purity using SEC-HPLC (see supplementary information, Table S2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!